Chiara Lico

Dr. Chiara Lico

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2006 in BMC Plant Biology
Verified
Journal Article
Open access
PDF file
LDLuca Dall'Osto
Luca Dall'Osto
CLChiara Lico
Chiara Lico
JAJean Alric
Jean Alric
GGGiovanni Giuliano
Giovanni Giuliano
Michel HavauxMichel Havaux
Michel Havaux
RBRoberto Bassi
Roberto Bassi
Background: Lutein is the most abundant xanthophyll in the photosynthetic apparatus of higher plants. It binds to site L1 of all Lhc proteins, whose occupancy is indispensable for protein folding and quenching chlorophyll triplets. Thus, the lack of a visible phenotype in mutants lacking lutein has been surprising. Results: We have re-assessed the lut2.1 phenotypes through biochemical and spectroscopic methods. Lhc proteins from the lut2.1 mutant compensate the lack of lutein by binding violaxanthin in sites L1 and L2. This substitution reduces the capacity for regulatory mechanisms such as NPQ, reduces antenna size, induces the compensatory synthesis of Antheraxanthin + Zeaxanthin, and prevents the trimerization of LHCII complexes. In vitro reconstitution shows that the lack of lutein per se is sufficient to prevent trimerization. lut2.1 showed a reduced capacity for state I – state II transitions, a selective degradation of Lhcb1 and 2, and a higher level of photodamage in high light and/or low temperature, suggesting that violaxanthin cannot fully restore chlorophyll triplet quenching. In vitro photobleaching experiments and time-resolved spectroscopy of carotenoid triplet formation confirmed this hypothesis. The npq1lut2.1 double mutant, lacking both zeaxanthin and lutein, is highly susceptible to light stress. Conclusion: Lutein has the specific property of quenching harmful 3Chl* by binding at site L1 of the major LHCII complex and of other Lhc proteins of plants, thus preventing ROS formation. Substitution of lutein by violaxanthin decreases the efficiency of 3Chl* quenching and causes higher ROS yield. The phenotype of lut2.1 mutant in low light is weak only because rescuing mechanisms of photoprotection, namely zeaxanthin synthesis, compensate for the ROS production. We conclude that zeaxanthin is effective in photoprotection of plants lacking lutein due to the multiple effects of zeaxanthin in photoprotection, including ROS scavenging and direct quenching of Chl fluorescence by binding to the L2 allosteric site of Lhc proteins.

10 March 2008 in Journal of Cellular Physiology
Verified
Journal Article
Closed access
PDF file
CLChiara Lico
Chiara Lico
Shawn ChenShawn Chen
Shawn Chen
LSLuca Santi
Luca Santi

1 August 2009 in Vaccine
Verified
Journal Article
Closed access
CLChiara Lico
Chiara Lico
CMCamillo Mancini
Camillo Mancini
PIPaola Italiani
Paola Italiani
Camilla BettiCamilla Betti
Camilla Betti
DBDiana Boraschi
Diana Boraschi
SBSelene Baschieri
Selene Baschieri

1 October 2006 in Journal of General Virology
Verified
Journal Article
Closed access
CLChiara Lico
Chiara Lico
FCFloriana Capuano
Floriana Capuano
GRGiovanni Renzone
Giovanni Renzone
MDMarcello Donini
Marcello Donini
CMCarla Marusic
Carla Marusic
SBSelene Baschieri
Selene Baschieri
The potexvirusPotato virus X(PVX) can be modified genetically to generate chimeric virus particles (CVPs) carrying heterologous peptides fused to coat protein (CP) subunits. A spontaneous PVX mutant expressing a truncated, but functional, form of the CP has been isolated. With the aim of exploiting this virus to display peptides useful for vaccine formulations, two novel viral expression vectors based on pPVX201 (bearing the wild-type PVX genome) were constructed encoding the truncated CP. Both vectors were able to produce infectious virus particlesin plantaand were used to insert a panel of sequences encoding peptides of biopharmaceutical interest as N-terminal fusions to the truncatedcpgene. The analysis of infection progression induced by the different constructs enabled identification of two important structural features of the fused peptide, namely tryptophan content and isoelectric point, critically affecting the formation of PVX CVPs and virus movement through the plant. These results are discussed in view of the rising interest in engineered plant viruses for development of peptide-based epitope vaccines.

5 January 2012 in Plant Cell Reports
Verified
Journal Article
Closed access
PDF file
CLChiara Lico
Chiara Lico
LSLuca Santi
Luca Santi
RTRichard Twyman
Richard Twyman
MPMario Pezzotti
Mario Pezzotti
Linda AvesaniLinda Avesani
Linda Avesani

17 November 2015 in Frontiers in Plant Science
Verified
Journal Article
Open access
PDF file
CLChiara Lico
Chiara Lico
EBEugenio Benvenuto
Eugenio Benvenuto
SBSelene Baschieri
Selene Baschieri
Potato virus X (PVX) is a single-stranded RNA plant virus, historically investigated in light of the detrimental effects on potato, the world's fourth most important food commodity. The study of the interactions with cells, and more generally with the plant, both locally and systemically, significantly contributed to unveil the mechanisms underlying gene silencing, fundamental not only in plant virology but also in the study of gene expression regulation. Unraveling the molecular events of PVX infection paved the way for the development of different viral expression vectors and consequential applications in functional genomics and in the biosynthesis of heterologous proteins in plants. Apart from that, the ease of manipulation and the knowledge of the virus structure (particle dimensions, shape and physicochemical features) are inspiring novel applications, mainly focused on nanobiotechnology. This review will lead the reader in this area, spanning from fundamental to applied research, embracing fields from plant pathology to vaccine and drug-targeted delivery, imaging and material sciences. Due to the versatile moods, PVX holds promise to become an interesting nanomaterial, in view to create the widest possible arsenal of new “bio-inspired” devices to face evolving issues in biomedicine and beyond.